138 related articles for article (PubMed ID: 24628975)
1. Carbon monoxide-releasing molecule attenuates allograft airway rejection.
Ohtsuka T; Kaseda K; Shigenobu T; Hato T; Kamiyama I; Goto T; Kohno M; Shimoda M
Transpl Int; 2014 Jul; 27(7):741-7. PubMed ID: 24628975
[TBL] [Abstract][Full Text] [Related]
2. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
4. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
6. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
[TBL] [Abstract][Full Text] [Related]
7. Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium.
Genden EM; Iskander AJ; Bromberg JS; Mayer L
Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):118-23. PubMed ID: 12525206
[TBL] [Abstract][Full Text] [Related]
8. Immune cells in a mouse airway model of obliterative bronchiolitis.
Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel reduces post-transplant obliterative bronchiolitis.
Preidl RH; Eckl S; Ramsperger-Gleixner M; Koch N; Spriewald BM; Weyand M; Ensminger SM
Transpl Int; 2013 Oct; 26(10):1038-48. PubMed ID: 23952051
[TBL] [Abstract][Full Text] [Related]
10. Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts.
Raissadati A; Nykänen AI; Tuuminen R; Syrjälä SO; Krebs R; Arnaudova R; Rouvinen E; Wang X; Poller W; Lemström KB
Transpl Int; 2015 Dec; 28(12):1416-25. PubMed ID: 26174800
[TBL] [Abstract][Full Text] [Related]
11. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
[TBL] [Abstract][Full Text] [Related]
12. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
[TBL] [Abstract][Full Text] [Related]
13. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
15. Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
Ohtsuka T; Changelian PS; Bouïs D; Noon K; Harada H; Lama VN; Pinsky DJ
J Immunol; 2010 Jul; 185(2):1321-9. PubMed ID: 20548026
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation.
Chen P; Farivar AS; Mulligan MS; Madtes DK
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):464-72. PubMed ID: 16388023
[TBL] [Abstract][Full Text] [Related]
17. Hierarchical contributions of allorecognition pathways in chronic lung rejection.
Chalermskulrat W; Neuringer IP; Brickey WJ; Felix NJ; Randell SH; Ting JP; Aris RM
Am J Respir Crit Care Med; 2003 Apr; 167(7):999-1007. PubMed ID: 12446274
[TBL] [Abstract][Full Text] [Related]
18. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
[TBL] [Abstract][Full Text] [Related]
19. FK506 combined with GM6001 prevents tracheal obliteration in a mouse model of heterotopic tracheal transplantation.
Li Y; Shu P; Tang L; Yang X; Fan J; Zhang X
Transpl Immunol; 2019 Dec; 57():101244. PubMed ID: 31526865
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
Mesaki K; Yamane M; Sugimoto S; Fujisawa M; Yoshimura T; Kurosaki T; Otani S; Miyoshi S; Oto T; Matsukawa A; Toyooka S
Surg Today; 2019 May; 49(5):443-450. PubMed ID: 30617600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
